These are two important verdict for all patients injured by transvaginal mesh as they are “bellwether” trials. Bellwether is a word lawyers like to use to say “predictor” or, even, “first in line,” it is a trial that can help to predict and encourage the flow and verdicts of future trials for the same issues. Both the $3.27 million and the $73 million verdict are groundbreakers, verdicts that could help the countless women in our country who have been injured by transvaginal mesh devices.
And that is the heart of transvaginal mesh litigation: The patients involved in these two groundbreaking trials had no idea of the risks involved with transvaginal mesh. They were both told that implanting the transvaginal mesh device was a minimally invasive procedure. Only that couldn’t be farther from the truth. And while these vitcims were not adequately warned of the risks involved… both juries decided separately that the two companies involved in the trials knew them well.